title: Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
abstract: Ewing's sarcoma (EWS) cells accumulate elevated steady-state levels of poly (ADP-ribose) polymerase (PARP) mRNA and protein. To understand the molecular mechanisms underlying PARP upregulation, we cloned and analysed the 5'-flanking region of the PARP gene from EWS cells. Nucleotide sequence analysis demonstrated no variations in the PARP promoter region in EWS cells. The PARP promoter encompasses multiple binding motifs for the ETS transcription factor. We have also observed that there is a coordinated up-regulation of the expression of both PARP and ETS1, relative to cells of other human tumor types expressing lower levels of PARP. Transient co-expression of ETS1 in EWS cells resulted in a strong enhancement of PARP-promoter activity. The participation of ETS in the regulation of PARP gene expression was further demonstrated in EWS cells stably transfected with Ets1 antisense cDNA constructs. Antisense-mediated down-regulation of endogenous ETS1 resulted in the inhibition of PARP expression in EWS cells, and sensitized these cells to ionizing radiation. These data provide support for ETS regulation of PARP expression levels, and implicate ETS transcription factors in the radiation response of EWS cells.
authors.affiliation: Department of Radiation Medicine, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
authors.forename: V A
authors.initials: VA
authors.lastname: Soldatenkov
authors.forename: A
authors.initials: A
authors.lastname: Albor
authors.forename: B K
authors.initials: BK
authors.lastname: Patel
authors.forename: R
authors.initials: R
authors.lastname: Dreszer
authors.forename: A
authors.initials: A
authors.lastname: Dritschilo
authors.forename: V
authors.initials: V
authors.lastname: Notario
mesh_terms: D001483:Base Sequence; D002455:Cell Division / Q000235:genetics / Q000528:radiation effects; D002588:Cesium Radioisotopes; D005786:Gene Expression Regulation; D006131:Growth Inhibitors / Q000502:physiology; D006801:Humans; D008969:Molecular Sequence Data; D011065:Poly(ADP-ribose) Polymerases / Q000096:biosynthesis / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000502:physiology; D050784:Proto-Oncogene Protein c-ets-1; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D050783:Proto-Oncogene Proteins c-ets; D012512:Sarcoma, Ewing / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D015533:Transcriptional Activation; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D002588:Cesium Radioisotopes; C494041:ETS1 protein, human; D006131:Growth Inhibitors; D050784:Proto-Oncogene Protein c-ets-1; D011518:Proto-Oncogene Proteins; D050783:Proto-Oncogene Proteins c-ets; D014157:Transcription Factors; D011065:Poly(ADP-ribose) Polymerases